From small biotechs to academic organisations to big pharma companies, Biopharma Dealmakers works with a wide spectrum of clients in order to present their mission and partnering opportunities to a focused audience.

Below we present a number of testimonials from clients describing how valuable they have found the experience of being profiled in the Biopharma Dealmakers print publication.

  • “Very efficient and professional team.”
  • “The transition was smooth from sales to editorial team. The process with the editorial team was good and they were very helpful in taking our suggestions into account.”
    Alligator Bioscience
  • “It was a good opportunity to let other companies know what we are doing in the field of infectious diseases. This was our first experience and I cannot see room for improvement right now.”
  • “It was a very unique opportunity to work together […] I will selectively recommend [the service] to only the reliable companies.”
  • “Altogether, we were a very productive and well-interacting team. In this way, it was possible to put together a great article within a short period of time. We would be happy to work with Biopharma Dealmakers again.”
  • “[The entire process] took less of my time than expected and was much easier than I anticipated. We chose to have a figure drawn by the Nature staff artist, and were very happy with the result.”
    BioAxone BioSciences Inc
  • “I strongly believe Biopharma Dealmakers is one of the best ways to introduce ABL Bio and our innovative research. [The entire process] was an excellent experiences working with your team from the beginning of writing to the final version.”
    ABL Bio
  • “Yes, I would recommend [the service] and found [The entire process] professional”
    Oxford Vacmedix Ltd.
  • “We enjoyed working with BioPharma Dealmakers, Nature Biotechnology and Nature Reviews Drug Discovery as we educated their readers about Arcturus Therapeutics and increased the visibility of our LUNAR delivery and UNA Oligomer chemistry platform with other life science companies — and look forward to further opportunities to do so again.”
    Arcturus Therapeutics,
  • “Sanofi Pasteur has found the BioPharma Dealmakers business profiles to be an effective way to reach potential partners in the biotechnology community. Coordinating publication of the profiles with major international partnering meetings allows us to communicate our partnering interests to a large and interested audience on a regular basis.”
    Sanofi Pasteur
  • “We find the BioPharma Dealmakers profiles to be a successful way of raising the awareness of our offerings. We have used the outcome at both conferences and our websites to further promote our partnering capabilities in a consistent way. The people at Nature coordinated all activities and writing very well; they are very flexible in helping us through our everyday busy lives.”
    Novozymes Biopharma UK Ltd
  • “We find the Nature Biopharma Dealmakers business profiles a successful way to communicate our messages about Merck’s partnering interests and capabilities. We often hear from potential partners after they read the article.”